drug
clascoterone
Marketedupdated 3mo agoby Sun Pharmaceutical Industries Ltd
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 7- drugCB-03111 co-mentions · 1 sources
- druglatanoprost SR1 co-mentions · 1 sources
- drugLATANOPROST1 co-mentions · 1 sources
- drugXalatan1 co-mentions · 1 sources
- drug(clascoterone + latanoprost)1 co-mentions · 1 sources
- companyGlenmark Pharmaceuticals Ltd1 co-mentions · 1 sources
- tagDermatology1 co-mentions · 1 sources
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for acne and 1 investigational indication.
all catalysts(0)
nothing on the calendar yet
Trials studying clascoterone
- phase3A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss
- phase31% Clascoterone Cream for the Treatment Acne Vulgaris
- phase4A Study to Assess Sebaceous Gland Changes and Constituents of Sebum (Skin Oil) Induced by Clascoterone 1% Cream in Acne Patients
- phase4A Study Evaluating the Efficacy and Safety of Clascoterone Cream 1% in Skin of Color Patients With Acne
- phase3A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss (SCALP2)
- phase4A Study Assessing the Efficacy of Combined Use of Clascoterone 1% Cream and Adapalene 0.3% for the Treatment of Acne
- phase4A Study Assessing the Efficacy and Safety of Combined Use of Clascoterone 1% Cream and Duac Gel (Benzoyl Peroxide/Clindamycin) for the Treatment of Acne
- phase3Efficacy and Safety of Clascoterone Cream 1% in Facial Acne Vulgaris
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jan 12, 2027
146 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (8)
- Jul 25, 2030formulationUS 87854273.9y
- Feb 28, 2029formulationUS 94336282.5y
- Nov 20, 2028formulationUS 112073322.3y
- Aug 14, 2028method-of-use (U-2942)US 101596822.0y
- Jul 24, 2028formulationUS 119381411.9y
- Jul 24, 2028formulationUS 123370021.9y
- Jul 24, 2028method-of-use (U-2942)US 94864581.9y
- Jan 12, 2027method-of-use (U-2942)US 8143240146d
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 9m ago
Found something off?
comments(0)
5-min edit window · permanent after that